TKNO - Alpha Teknova, Inc.
IEX Last Trade
8.74
-0.030 -0.343%
Share volume: 12,056
Last Updated: Thu 26 Dec 2024 08:29:22 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$8.77
-0.03
-0.34%
Fundamental analysis
20%
Profitability
0%
Dept financing
9%
Liquidity
75%
Performance
30%
Performance
5 Days
11.98%
1 Month
22.68%
3 Months
90.69%
6 Months
566.67%
1 Year
140.22%
2 Year
67.32%
Key data
Stock price
$8.74
DAY RANGE
$8.56 - $9.17
52 WEEK RANGE
$1.21 - $9.72
52 WEEK CHANGE
$131.18
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Stephen Gunstream
Region: US
Website: teknova.com
Employees: 240
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: teknova.com
Employees: 240
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion.
Recent news